Identification of bone marrow micrometastases in patients with prostate cancer

No abstract is available for this paper.

• Publication year

  1994

• Venue

  Cancer

• Publication date

  1994-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1002/1097-0142(19941101)74:9<2533::AID-CNCR2820740922>3.0.CO;2-DPMID 7522952
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Sensitivity of immunohistochemistry and polymerase chain reaction in detecting prostate cancer cells in bone marrow.

  1994cited by this paper
• Influence of wide excision of the neurovascular bundle(s) on prognosis in men with clinically localized prostate cancer with established capsular penetration.

  1993cited by this paper
• Ability of preoperative serum prostate-specific antigen value to predict pathologic stage and DNA ploidy. Influence of clinical stage and tumor grade.

  1993cited by this paper
• Detection of micrometastatic prostate cancer cells in lymph nodes by reverse transcriptase-polymerase chain reaction.

  1993cited by this paper
• Stratification of pathologic features in radical prostatectomy specimens that are predictive of elevated initial postoperative serum prostate‐specific antigen levels

  1993cited by this paper
• Detection of hematogenous micrometastasis in patients with prostate cancer.

  1992cited by this paper
• Lower incidence of unsuspected lymph node metastases in 521 consecutive patients with clinically localized prostate cancer.

  1992cited by this paper
• Prediction of early relapse in patients with operable breast cancer by detection of occult bone marrow micrometastases.

  1991cited by this paper
• The risk of dying of prostate cancer in patients with clinically localized disease.

  1991cited by this paper
• Detection of neuroblastoma cells in blood.

  1990cited by this paper
• Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia

  1989cited by this paper
• Detection of Philadelphia chromosome-positive cells by the polymerase chain reaction following bone marrow transplant for chronic myelogenous leukemia.

  1989cited by this paper
• Human prostate specific antigen (PSA) gene: structure and linkage to the kallikrein-like gene, hGK-1.

  1989cited by this paper
• Radical prostatectomy. Patterns of local failure and survival in 67 patients.

  1988cited by this paper
• Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

  1988cited by this paper
• Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

  1987cited by this paper
• Micrometastases in bone marrow in patients with primary breast cancer: evaluation as an early predictor of bone metastases.

  1987cited by this paper
• Patient survival and local recurrence rate following radical prostatectomy for prostatic carcinoma.

  1986cited by this paper
• Prognostic factors in localized prostatic carcinoma.

  1985cited by this paper
• Complementary DNA sequence of a human cytoplasmic actin. Interspecies divergence of 3' non-coding regions.

  1983cited by this paper
• Radical surgery for prostatic cancer.

  1980cited by this paper
• Radical Surgery for Prostatic Cancer

  1980cited by this paper
• Separation and characteristics of tumor-infiltrating lymphocytes in man.

  1980cited by this paper

• Incidence, Risk Factors, and Clinical Characteristics of Late Biochemical Recurrence Following Robot‐Assisted Radical Prostatectomy

  2025cites this paper
• METCAM Is a Potential Biomarker for Predicting the Malignant Propensity of and as a Therapeutic Target for Prostate Cancer

  2023cites this paper
• Prostate cancer dormancy and recurrence.

  2021cites this paper
• Validating METCAM/MUC18 as a Novel Biomarker to Predict the Malignant Potential of Prostate Cancer at an Early Stage by Using a Modified Gold Nanoparticles-Based Lateral Flow Immunoassay

  2021cites this paper
• METCAM/MUC18 is a new early diagnostic biomarker for the malignant potential of prostate cancer: Validation with Western blot method, enzyme-linked immunosorbent assay and lateral flow immunoassay

  2020cites this paper
• Parallels between hematopoietic stem cell and prostate cancer disseminated tumor cell regulation.

  2019cites this paper
• HnRNPM is a potential mediator of YY1 which promotes EMT in prostate cancer cells

  2019cites this paper
• Detection and isolation of disseminated tumor cells in bone marrow of patients with clinically localized prostate cancer

  2019cites this paper
• Human METCAM/MUC18 is a New Diagnostic Marker of and a Driver for Promoting and its Specific siRNAs, Derived Oligopeptides and Antibodies be Used for Decreasing the Malig- nant Progression of Prostate Cancer

  2018cites this paper
• Osteoclast inhibitors to prevent bone metastases in men with high-risk, non-metastatic prostate cancer: A systematic review and meta-analysis

  2018cites this paper
• Minimal Residual Disease in Prostate Cancer.

  2018cites this paper
• Opposing roles of TGFβ and BMP signaling in prostate cancer development

  2017cites this paper
• The Bone Marrow Microenvironment as a Regulator of Tumor Dormancy

  2016cites this paper
• Human METCAM/MUC18 is a New Diagnostic Marker of and a Driver for Promoting and its Specific SiRNAs, Derived Oligopeptides and Antibodies be used for Decreasing the Malignant Progression of Prostate Cancer

  2016cites this paper
• When Prostate Cancer Circulates in the Bloodstream

  2015cites this paper
• Human METCAM / MUC 18 as a Novel Biomarker to Drive and its Specific SiRNAs to Block the Malignant Progression of Prostate Cancer

  2015cites this paper
• Blood Clot Formation Does Not Affect Metastasis Formation or Tumor Growth in a Murine Model of Breast Cancer

  2014cites this paper
• Aspirin Use after a Prostate Cancer Diagnosis and Cancer Survival in a Prospective Cohort

  2012cites this paper
• Circulating tumor cells in prostate cancer: a potential surrogate marker of survival.

  2012cites this paper
• Micrometastasis: Detection methods and clinical importance

  2011cites this paper
• Significance of micrometastases in prostate cancer.

  2008cites this paper
• The detection and isolation of viable prostate-specific antigen positive epithelial cells by enrichment: a comparison to standard prostate-specific antigen reverse transcriptase polymerase chain reaction and its clinical relevance in prostate cancer.

  2007cites this paper
• Prostate-specific Antigen Messenger RNA Is Expressed in Non-Prostate Cells : Implications for Detection of Micrometastases 1

  2006cites this paper
• Detection of Early Tumor Dissemination in Patients With Breast Cancer

  2006cites this paper
• Increased expression of MUC18 correlates with the metastatic progression of mouse prostate adenocarcinoma in the TRAMP model.

  2005cites this paper
• Oral treatment of the TRAMP mice with doxazosin suppresses prostate tumor growth and metastasis

  2005cites this paper
• Cintilografia óssea no câncer de próstata

  2005cites this paper
• Recent Developments in Nuclear Medicine in the Management of Bone Metastases: A Review and Perspective

  2005cites this paper
• DETECTION OF PROSTATE SPECIFIC mRNAs IN CIRCULATION AND IN PROSTATIC TISSUE

  2005cites this paper
• Cancer Treatment and Research

  2005cites this paper
• Changes in Prostate-Specific Antigen (PSA) Level Correlate with Growth Inhibition of Prostate Cancer Cells Treated in Vitro with a Novel Anticancer Drug, Irofulven

  2004cites this paper
• Molecular staging by RT-PCR analysis for PSA and PSMA in peripheral blood and bone marrow samples is an independent predictor of time to biochemical failure following radical prostatectomy for clinically localized prostate cancer

  2004cites this paper
• The molecular staging of prostate cancer

  2004cites this paper
• Repetitive and site-specific molecular staging of prostate cancer using nested reverse transcriptase polymerase chain reaction for prostate specific antigen and prostate specific membrane antigen

  2004cites this paper
• Adjunctive therapy for men with high risk localized and locally advanced prostate cancer: targeting disseminated tumor cells.

  2004cites this paper
• The basic biology of metastasis.

  2004cites this paper
• Clinical usefulness of RT-PCR detection of hematogenous prostate cancer spread

  2004cites this paper
• Prognosis of Minimal Residual Disease in Bone Marrow, Blood and Lymph Nodes in Breast Cancer

  2003cites this paper
• Prostate Cancer in Lymph Nodes Transcription-PCR for the Detection of Micrometastatic Comparison of Immunohistochemistry with Reverse Updated Version

  2003cites this paper
• The evolving role of pelvic radiation therapy.

  2003cites this paper
• Old and New Research into Micrometastases in Prostate Cancer

  2003cites this paper
• Comparison of immunohistochemistry with reverse transcription-PCR for the detection of micrometastatic prostate cancer in lymph nodes.

  2003cites this paper
• RT-PCR for PSA as a prognostic factor for patients with clinically localized prostate cancer treated with radiotherapy.

  2003cites this paper
• Metastasis suppression: the evolving role of metastasis suppressor genes for regulating cancer cell growth at the secondary site.

  2003cites this paper
• Preoperative Staging of Prostate Cancer: The Role of Molecular Markers

  2003cites this paper
• Prostate carcinoma

  2003cites this paper
• Prostate cancer: radical prostatectomy.

  2003cites this paper
• Detection and isolation of prostate cancer cells from peripheral blood and bone marrow.

  2003cites this paper
• Detection of MUC1 and keratin 19 mRNAs in the bone marrow by quantitative RT-PCR predicts the risk of distant metastasis in breast cancer patients

  2003cites this paper
• Increased risk of systemic relapses associated with bone marrow micrometastasis and circulating tumor cells in localized ewing tumor.

  2003cites this paper
• Increased R isk o f S ystemic R elapses A ssociated W ith B one Marrow M icrometastasis a nd C irculating T umor C ells i n Localized E wing T umor

  2003cites this paper
• RT-PCR for tyrosinase expression as a molecular marker in malignant melanoma.

  2002cites this paper
• Detektion von Prostata-spezifisches Antigen (PSA-)mRNA-exprimierenden Zellen im peripheren Blut mittels Reverse-transcription-nested-Polymerasekettenreaktion (RT-nested-PCR)

  2002cites this paper
• Future directions for unsealed source radionuclide therapy for bone metastases

  2002cites this paper
• Intraoperative molecular detection of circulating tumor cells by reverse transcription-polymerase chain reaction in patients with biliary-pancreatic cancer is associated with hematogenous metastasis

  2002cites this paper
• 7 The role of MUC18 in prostate carcinoma

  2002cites this paper
• The comparative values of bone marrow aspirate and trephine for obtaining bone scan-targeted metastases from hormone-refractory prostate cancer

  2002cites this paper
• A review of the efficacy of bone scanning in prostate and breast cancer.

  2002cites this paper
• Molecular markers in prostate cancer: the role in preoperative staging.

  2002cites this paper
• Presence of circulating prostate cancer cells in African American males adversely affects survival.

  2002cites this paper
• Perioperative detection of circulating cancer cells in patients with colorectal hepatic metastases.

  2002cites this paper
• Changes in prostate-specific antigen (PSA) level correlate with growth inhibition of prostate cancer cells treated in vitro with a novel anticancer drug, irofulven.

  2001cites this paper
• Occult metastasis.

  2001cites this paper
• Lethal Metastatic Human Prostate Cancer

  2001cites this paper
• Conversion of nested reverse-transcriptase polymerase chain reaction from positive to negative status at peripheral blood during androgen ablation therapy is associated with long progression-free survival in stage D2 prostate cancer patients.

  2001cites this paper
• The role of imaging studies and molecular markers for selecting candidates for radical prostatectomy.

  2001cites this paper
• Proliferation of prostate cancer cells in the bone marrow predicts recurrence in patients with localized prostate cancer

  2001cites this paper
• [Detection of micrometastases and circulating tumour cells using molecular biology technics in solid tumours].

  2001cites this paper
• Malignant cytological washings from prostate specimens: an independent predictor of biochemical progression after radical prostatectomy.

  2001cites this paper
• Androgen Sensitivity of Prostate Cancer

  2000cites this paper
• Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.

  2000cites this paper
• [Conditions for the development of a program of reverse transcriptase-polymerase chain reaction for molecular staging of prostatic cancer].

  2000cites this paper
• Androgen sensitivity of prostate cancer: special reference to prognostic factors and androgen receptor

  2000cites this paper
• Condiciones de desarrollo de un programa de reacción en cadena de la polimerasa-transcriptasa reversa para el estadiaje molecular del cáncer de próstata

  2000cites this paper
• REVIEWS — Tumour micrometastases: the influence of angiogenesis

  2000cites this paper
• MicrometÆstasis en tumores sÛlidos: ¿quØ son y quØ significa su detecciÛn por mØtodos de inmunohistoquÌmica?

  2000cites this paper
• Characterization of a newly established human pancreatic carcinoma cell line, UK Pan‐1

  2000cites this paper
• The role of prostate specific antigen measurement in the detection and management of prostate cancer.

  2000cites this paper
• Analytical variables of reverse transcription-polymerase chain reaction-based detection of disseminated prostate cancer cells.

  2000cites this paper
• RT‐PCR‐Based Detection of Occult Disseminated Tumor Cells in Peripheral Blood and Bone Marrow of Patients with Solid Tumors: An Overview

  2000cites this paper
• Prostate tumor progression and prognosis. interplay of tumor and host factors.

  2000cites this paper
• Detection of extraprostatic prostate cells utilizing reverse transcription-polymerase chain reaction.

  2000cites this paper
• Molecular detection of low‐level disease in patients with cancer

  2000cites this paper
• Significance of the CAG repeat polymorphism of the androgen receptor gene in prostate cancer progression.

  2000cites this paper
• Androgen receptor gene amplification at primary progression predicts response to combined androgen blockade as second line therapy for advanced prostate cancer.

  2000cites this paper
• Micrometástasis en tumores sólidos: ¿Qué son y qué significa su detección por métodos de inmunohistoquímica?

  2000cites this paper
• Detection of minimal residual disease in patients with cancer: a review of techniques, clinical implications, and emerging therapeutic consequences.

  2000cites this paper
• UTILIDAD DE LA REACCIÓN EN CADENA DE LA POLIMERASA (PCR) EN LA DETECCIÓN DE CELULAS METASTASICAS EN EL MELANOMA MALIGNO DE UVEA

  2000cites this paper
• Endocrine-Related Cancer ( 2000 ) 7 37 – 51 The role of prostate specific antigen measurement in the detection and management of prostate cancer

  2000cites this paper
• Tumour micrometastases: the influence of angiogenesis.

  2000cites this paper
• Expression and prognostic value of CD44 isoforms in transitional cell carcinoma of renal pelvis and ureter.

  1999cites this paper
• Detection of Disseminated Epithelial Tumor Cells: Methods and Clinical Implications

  1999cites this paper
• Stagingprobleme beim Prostatakarzinom aus urologischer Sicht

  1999cites this paper
• Cellular proliferation and prevalence of micrometastatic cells in the bone marrow of patients with clinically localized prostate cancer.

  1999cites this paper
• Detection of circulating prostate specific antigen expressing prostatic cells in the bone marrow of radical prostatectomy patients by sensitive reverse transcriptase polymerase chain reaction.

  1999cites this paper
• Detection of neuroblastoma in bone marrow by immunocytology: is a single marrow aspirate adequate?

  1999cites this paper
• Blinded evaluation of reverse transcriptase-polymerase chain reaction prostate-specific antigen peripheral blood assay for molecular staging of prostate cancer.

  1999cites this paper
• Significance of genetic-based factors for prostate cancer progression

  1999cites this paper
• Assessment of patients with metastatic transitional cell carcinoma of the urinary tract.

  1999cites this paper
• Nucleic Acid Based Techniques for the Detection of Rare Cancer Cells in Clinical Samples

  1999cites this paper